Trial site
Hanyang University Guri Hospital
- 24running trials
- 8closed trials
The trials here
What the 32 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes8 trials
- Chronic kidney disease6 trials
- Obesity5 trials
- Alzheimer disease4 trials
- Stroke4 trials
- Atrial fibrillation2 trials
- Coronary artery disease2 trials
- Crohn's disease2 trials
- Mild cognitive impairment2 trials
- Antiphospholipid syndrome1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Liver and biliary tract cancer1 trial
- and 3 more
- Phase
- Phase 320 trials
- Phase 25 trials
- Phase 44 trials
- Phase 2/31 trial
- Status
- Recruiting11 trials
- Active, not recruiting7 trials
- Completed6 trials
- Not yet recruiting6 trials
- Terminated2 trials
- Lead sponsor
- Eli Lilly and Company13 trials
- Seoul National University Hospital3 trials
- Aptabio Therapeutics, Inc.1 trial
- AriBio Co., Ltd.1 trial
- Bayer1 trial
- and 13 more
Running trials
Not yet recruiting
Not yet recruiting
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Recruiting
Recruiting
First-Line Lenvatinib in Child-Pugh B Patients With HCC Unsuitable for Curative Treatment
Recruiting
Not yet recruiting
Dronedarone Rhythm Intervention for Early Atrial Fibrillation
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Recruiting
Recruiting
A Study of Brenipatide in Participants With Alcohol Use Disorder
Recruiting
Recruiting
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
Recruiting
Recruiting
Recruiting
Efficacy and Safety Study of Isuzinaxib in Subjects With DKD
Recruiting
Recruiting
Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity4 recruiting
- Chronic kidney disease3 recruiting
- Stroke3 recruiting
- Type 2 diabetes3 recruiting
- Coronary artery disease2 recruiting
- Alzheimer disease1 recruiting
- Atrial fibrillation1 recruiting
- Crohn's disease1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Liver and biliary tract cancer1 recruiting
- Mild cognitive impairment1 recruiting
- Peripheral artery disease1 recruiting
- Schizophrenia1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Terminated
Terminated
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease
Completed
Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With Hypertriglyceridaemia
Site data: ClinicalTrials.govUpdated 18 Nov 2026